Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory of Molecular Genetics |
RCV000782004 | SCV000920464 | pathogenic | not provided | 2018-01-09 | criteria provided, single submitter | clinical testing | |
Tartaglia Lab, |
RCV000492407 | SCV000925236 | pathogenic | Rahman syndrome | 2019-05-01 | criteria provided, single submitter | research | |
Institute of Human Genetics, |
RCV000492407 | SCV001440316 | pathogenic | Rahman syndrome | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Laboratoire de Génétique Moléculaire, |
RCV000782004 | SCV001468922 | pathogenic | not provided | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000782004 | SCV001811898 | pathogenic | not provided | 2020-04-06 | criteria provided, single submitter | clinical testing | Frameshift variant in the C-terminus predicted to result in protein truncation, as the last 72 amino acids are lost and replaced with 47 incorrect amino acids; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 31910894, 31447100, 31400068, 28475857, 25081361, 29704315) |
3billion | RCV000492407 | SCV003841324 | pathogenic | Rahman syndrome | 2023-02-23 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. This variant was predicted to result in a loss or disruption of normal protein function through protein truncation. Multiple pathogenic variants are reported in the predicted truncated region. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000428606). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. |
Pittsburgh Clinical Genomics Laboratory, |
RCV000492407 | SCV005397415 | pathogenic | Rahman syndrome | 2023-02-17 | criteria provided, single submitter | clinical testing | This sequence variant is a one-nucleotide duplication (dupC) at coding position 441 in the H1-4 gene. This variant has been referred to as c.437dupC and c.441dup in the published literature. This duplication results in a premature termition sigl 48 codons downstream of the frameshift introduced at codon 148. This variant is absent from the gnomAD population database (0 of approximately 230,000 alleles). This is a previously reported variant (ClinVar) that has been identified in multiple D sequencing studies in individuals expressing variable clinical phenotypes including, but not limited to, intellectual disability, autism, microcephaly, seizures, brain atrophy, scoliosis, hip dislocation, dysmorphic features, hyperpigmented lesions in the trunk and distinctive facial gestalt (PMID: 28475857, 29704315, 31130284, 31400068). An in vitro functiol study showed that this variant disrupts proper compaction of D causing a dramatic reduction in proliferation rate and accelerated senescence of patient derived cultured cells (PMID: 31447100). Given this information, we consider this a pathogenic variant. ACMG Criteria: PM2, PS3, PS4, PVS1 |
OMIM | RCV000492407 | SCV000580688 | pathogenic | Rahman syndrome | 2017-06-27 | no assertion criteria provided | literature only | |
Clinical Genetics Laboratory, |
RCV000492407 | SCV002011701 | pathogenic | Rahman syndrome | 2021-09-13 | no assertion criteria provided | clinical testing | |
Department of Otolaryngology, |
RCV003984842 | SCV004801121 | pathogenic | Auditory neuropathy spectrum disorder | 2023-10-08 | no assertion criteria provided | clinical testing |